Inflammatory Myopathies and Dermatomyositis

External reference: https://openalex.org/T11724

  1. TMP/SMX use was linked to fewer severe infections in IIM
    Trimethoprim-sulfamethoxazole reduces severe infection risk in idiopathic inflammatory myopathy patients receiving immunosuppressive therapy, with significant protection against respiratory tract.